L. Hoigebazar et al. / Bioorg. Med. Chem. 19 (2011) 2176–2181
2181
(revised in 1996) were observed throughout. The mouse colon can-
References and notes
cer cell line CT-26 was grown in RPMI 1640 medium containing
10% fetal bovine serum and 1% antibiotics. Cells were washed with
10 mL of PBS by centrifugation (3000 rpm). Balb/c mice were
injected subcutaneously in right shoulders with 2 ꢁ 105/0.1 mL
CT-26 cells, and 14 days later, 68Ga-labeled agents (0.37 MBq/
0.1 mL) were injected intravenously into each mouse via a tail vein.
Mice were sacrificed by decapitation at various times (10, 30, 60,
and 120 min) after radiotracer administration. Tumor, blood, mus-
cle, and other organs were then excised, blotted, weighed, and
counted. Results are expressed as percentages of injected doses
per gram of tissue (% ID/g).
1. Rockwell, S.; Dobrucki, I. T.; Kim, E. Y.; Marrison, S. T.; Vu, V. T. Curr. Mol. Med.
2009, 9, 442.
2. Dehdashti, F.; Grigsby, P. W.; Lewis, J. S.; Laforest, R.; Siegel, B. A.; Welch, M. J. J.
Nucl. Med. 2008, 49, 201.
3. Shimizu, S.; Eguchi, Y.; Kamiike, W.; Itoh, Y.; Hasegawa, J.; Yamabe, K.; Otsuki,
Y.; Matsuda, H.; Tsujimoto, Y. Cancer Res. 1996, 56, 2161.
4. Steinbach, J. P.; Wolburg, H.; Klumpp, A.; Probst, H.; Weller, M. Cell Death Differ.
2003, 10, 823.
5. Vavere, A. L.; Lewis, J. S. J. Chem. Soc., Dalton Trans. 2007, 4893.
6. Lee, S. T.; Scott, A. M. Semin. Nucl. Med. 2007, 37, 451.
7. Kumar, P.; Emami, S.; Kresolek, Z.; Yang, J.; McEwan, A. J.; Wiebe, L. I. Med.
Chem. 2009, 5, 118.
8. Kumar, P.; Naimi, E.; McEwan, A. J.; Wiebe, L. I. Bioorg. Med. Chem. 2010, 18, 2255.
9. Piert, M.; Machulla, H. J.; Picchio, M.; Reischl, G.; Ziegler, S.; Kumar, P.; Wester, H.
J.; Beck, R.; McEwan, A. J.; Wiebe, L. I.; Schwaiger, M. J. Nucl. Med. 2005, 46, 106.
10. Tewson, T. J. Nucl. Med. Biol. 1997, 24, 755.
11. Mallia, M. B.; Subramanian, S.; Mathur, A.; Sarma, H. D.; Venkatesh, M.;
Banerjee, S. Bioorg. Med. Chem. Lett. 2008, 18, 5233.
4.10. Small-animal PET studies
CT-26 cells (2 ꢁ 105 cells) in normal saline (0.1 mL) were subcu-
taneously injected into mouse right shoulders. The tumors grew to
a diameter of ꢂ15 mm in 14 days. 68Ga-4 (24.1 MBq/0.15 mL) and
68Ga-5 (39.3 MBq/0.15 mL) were intravenously injected into tu-
mor-bearing mice via tail veins. Mice were anesthetized with 2%
isoflurane and PET images were obtained at 30 and 60 min post-
injection. Acquired 3-dimensional emission data was recon-
structed to temporally framed sonograms by Fourier rebinning
using an ordered subset expectation maximization reconstruction
algorithm without attenuation correction. Images were visualized
using ASIPro VM 5.0 software.
Image and region of interest (ROI) analyses of PET data sets
were performed using ASIPro software. The spherical ROIs of radius
1.5 mm placed in tumors and muscles were collected, and mean
(value/pixel) and standard deviation were determined. SUV values
were calculated using the formula, SUV = CCF/(injected dose/body
weight).
12. Riche, F.; d’Hardemare, A. D.; Sepe, S.; Riou, L.; Fagret, D.; Vidal, M. Bioorg. Med.
Chem. Lett. 2001, 11, 71.
13. Linder, K. E.; Chan, Y. W.; Cyr, J. E.; Malley, M. F.; Nowotnik, D. P.; Nunn, A. D. J.
Med. Chem. 1994, 37, 9.
14. Aboagye, E. O.; Lewis, A. D.; Johnson, A.; Workman, P.; Tracy, M.; Huxham, I. M.
Br. J. Cancer 1995, 72, 312.
15. Nunn, A.; Linder, K.; Strauss, H. W. Eur. J. Nucl. Med. 1995, 22, 265.
16. Takasawa, M.; Moustafa, R. R.; Baron, J. C. Stroke 2008, 39, 1629.
17. Bejot, R.; Kersemans, V.; Kelly, C.; Carroll, L.; King, R. C.; Gouverneur, V. Nucl.
Med. Biol. 2010, 37, 565.
18. Cairns, R. A.; Bennewith, K. L.; Graves, E. E.; Giaccia, A. J.; Chang, D. T.; Denko, N.
C. Clin. Cancer Res. 2009, 15, 7170.
19. Stypinski, D.; Wiebe, L. I.; Mercer, J. R. J. Pharm. Biomed. Anal. 1998, 16, 1067.
20. Rigo, P.; Paulus, P.; Kaschten, B. J.; Hustinx, R.; Bury, T.; Jerusalem, G.; Benoit, T.
Eur. J. Nucl. Med. 1996, 23, 1641.
21. Kaira, K.; Endo, M.; Abe, M.; Nakagawa, K.; Ohde, Y.; Okumura, T.; Takahashi,
T.; Murakami, H.; Tsuya, A.; Nakamura, Y.; Naito, T.; Hayashi, I.; Serizawa, M.;
Koh, Y.; Hanaoka, H.; Tominaga, H.; Oriuchi, N.; Kondo, H.; Nakajima, T.;
Yamamoto, N. J. Clin. Oncol. 2010, 28, 3746.
22. Hasebe, M.; Yoshikawa, K.; Ohashi, S.; Toubaru, S.; Kawaguchi, K.; Sato, J.;
Mizoe, J.; Tsujii, H. Mol. Imaging Biol. 2010, 12, 554.
23. Van Laere, K.; Clerinx, K.; D’Hondt, E.; de Groot, T.; Vandenberghe, W. J. Nucl.
Med. 2010, 51, 588.
24. Herzog, H.; Rosch, F.; Stocklin, G.; Lueders, C.; Qaim, S. M.; Feinendegen, L. E. J.
Nucl. Med. 1993, 34, 2222.
Where, CCF (decay corrected activity concentration) was calcu-
lated using the formula.
25. Thakur, M. L.; Aruva, M. R.; Gariepy, J.; Acton, P.; Rattan, S.; Prasad, S.;
Wickstrom, E.; Alavi, A. J. Nucl. Med. 2004, 45, 1381.
26. Jeong, J. M.; Hong, M. K.; Chang, Y. S.; Lee, Y. S.; Kim, Y. J.; Cheon, G. J.; Lee, D. S.;
Chung, J. K.; Lee, M. C. J. Nucl. Med. 2008, 49, 830.
CCF ¼ radioactivity ꢁ branching ratio ꢁ ROI
ðMBq=mLÞ
ðvalue=pixelÞ
ð0:891 for 68GaÞ
ðmCi=mLÞ
27. Shetty, D.; Jeong, J. M.; Ju, C. H.; Kim, Y. J.; Lee, J. Y.; Lee, Y. S.; Lee, D. S.; Chung, J.
K.; Lee, M. C. Bioorg. Med. Chem. 2010, 18, 7338.
28. Shetty, D.; Jeong, J. M.; Ju, C. H.; Lee, Y. S.; Jeong, S. Y.; Choi, J. Y.; Yang, B. Y.; Lee,
D. S.; Chung, J. K.; Lee, M. C. Nucl. Med. Biol. 2010, 37, 893.
29. Yang, B. Y.; Jeong, J. M.; Kim, Y. J.; Choi, J. Y.; Lee, Y. S.; Lee, D. S.; Chung, J. K.;
Lee, M. C. Nucl. Med. Biol. 2010, 37, 149.
30. Shetty, D.; Lee, Y. S.; Jeong, J. M. Nucl. Med. Mol. Imaging 2010, 44, 233.
31. Breeman, W. A.; Verbruggen, A. M. Eur. J. Nucl. Med. Mol. Imaging 2007, 34, 978.
32. Shetty, D.; Choi, S. Y.; Jeong, J. M.; Hoigebazar, L.; Lee, Y. S.; Lee, D. S.; Lee, M. C.;
Chung, J. K. Eur. J. Inorg. Chem. 2010, 5432.
Acknowledgments
This research was supported partly by the National Research
Laboratory Program of NRF (R0A-2008-000-20116-0) and the Con-
verging Research Program funded by MEST (2010K001055).
33. Velikyan, I.; Beyer, G. J.; Langstrom, B. Bioconjugate Chem. 2004, 15, 554.
34. Jeong, J. M.; Kim, Y. J.; Lee, Y. S.; Lee, D. S.; Chung, J. K.; Lee, M. C. Nucl. Med. Mol.
Imaging 2009, 43, 330.
Supplementary data
35. Benetollo, F.; Bombieri, G.; Calabi, L.; Aime, S.; Botta, M. Inorg. Chem. 2003, 42,
148.
36. Hoigebazar, L.; Jeong, J. M.; Choi, S. Y.; Choi, J. Y.; Shetty, D.; Lee, Y. S.; Lee, D. S.;
Chung, J. K.; Lee, M. C.; Chung, Y. K. J. Med. Chem. 2010, 53, 6378.
37. Mukai, T.; Suwada, J.; Sano, K.; Okada, M.; Yamamoto, F.; Maeda, M. Bioorg.
Med. Chem. 2009, 17, 4285.
Supplementary data associated with this article can be found, in
include MOL files and InChiKeys of the most important compounds
described in this article.